Results 31 to 40 of about 252,964 (178)

MDR-TB TREATMENT UPDATE

International Journal of Infectious Diseases, 2023
Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. Conventional therapy for RR-TB is more toxic, less effective, and much more costly than drug-susceptible TB.
openaire   +2 more sources

MDR-TB in Pakistan: Challenges, efforts, and recommendations

Annals of Medicine & Surgery, 2022
Tuberculosis (TB), a global health concern is also a leading cause of mortality and morbidity across Pakistan affecting a major proportion of the population. The absence of an integrated system to control the spread of TB has led to a rise in multidrug resistant strains of TB (MDR-Tb) which do not exhibit any sensitivity towards the first line therapy ...
Khan, Mahad Ahmed, Bilal, Wajeeha, Asim, Hanzla, Rahmat, Zainab Syyeda, Essar, Mohammad Yasir, Ahmad, Shoaib   +5 more
openaire   +2 more sources

Prevalence of multidrug-resistant tuberculosis at a regional drug-resistant tuberculosis center of Maharashtra

Indian Journal of Respiratory Care, 2020
Introduction: Multidrug-resistant tuberculosis (MDR-TB) has created a significant health problem in most of the countries, and it is an obstacle to effective TB control.
Gauri Suhas Kulkarni, Supriya Dhakne Palwe, Nilesh P Patil, Abhijit J Telkhade, Jui Kadukar   +4 more
doaj   +1 more source

Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008. [PDF]

, 2012
SETTING AND OBJECTIVE: To describe trends in drug-resistant tuberculosis (TB) in two gold-mining workforces, South Africa, 2002-2008. DESIGN: TB programme data analysis.
Fielding, K. L., van Halsema, CL, Churchyard, GJ, Churchyard, G. J., Chihota, VN, Grant, AD, Chihota, V. N., Grant, A. D., Fielding, KL, van Halsema, C. L., Lewis, J. J., Lewis, JJ   +11 more
core   +1 more source

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019

Emerging Infectious Diseases, 2022
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional ...
Yousra Kherabi, Mathilde Fréchet-Jachym, Christophe Rioux, Yazdan Yazdanpanah, Frédéric Méchaï, Valérie Pourcher, Jérôme Robert, Lorenzo Guglielmetti   +7 more
doaj   +1 more source

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. [PDF]

, 2011
BACKGROUND: Sudan is a large country with a diverse population and history of civil conflict. Poverty levels are high with a gross national income per capita of less than two thousand dollars.
Bottomley, Christian, McNerney Ruth, Ali Ahmed B, Salih, Abdel Latif Ga, McNerney, Ruth, Mohammed S Ali, Ruth McNerney, Fadl-Elmula, Imad, Christian Bottomley, Ali, Ahmed B, Ghada S Sharaf Eldin, Imad Fadl-Elmula, Ali, Mohammed S, Mallard, Kim, Abdel Latif GA Salih, Bottomley Christian, Ahmed B Ali, Salih Abdel Latif GA, Fadl-Elmula Imad, Sharaf Eldin, Ghada S, Ali Mohammed S, Kim Mallard, Sharaf Eldin Ghada S, Mallard Kim   +23 more
core   +2 more sources

Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study [PDF]

Epidemiology and Health, 2019
OBJECTIVES The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major challenge for the global control of tuberculosis (TB). The aim of this study was to determine the risk factors associated with MDR-TB in Sudan.
Adel Hussein Elduma, Mohammad Ali Mansournia, Abbas Rahimi Foroushani, Hamdan Mustafa Hamdan Ali, Asrar M A/Salam Elegail, Asma Elsony, Kourosh Holakouie-Naieni   +6 more
doaj   +1 more source

MDR-TB data

, 2019
This is the dataset for my MDR-TB ...
zhijie zhang (7141082)
core   +1 more source

Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. [PDF]

, 2015
BACKGROUND: Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices.
David Moore, Qazi, Fahad, Qadeer Ejaz, Qazi Fahad, Moore David, Moore D., Fahad Qazi, Katherine Fielding, Fatima R., Khan M.S., Khan, Mishal S, Mishal S Khan, Qadeer E., Qazi F., Ejaz Qadeer, Qadeer, Ejaz, Fielding Katherine, Fielding, Katherine, Moore, David, Razia Fatima, Fatima Razia, Fielding K., Fatima, Razia, Khan Mishal S.   +23 more
core   +1 more source

Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents

Frontiers in Medicine, 2023
BackgroundThere are few studies on medical conditions associated with the development of drug-resistant TB.ObjectiveWe investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.Materials
Jinkyeong Park, Yoonki Hong, Ji Young Hong   +2 more
doaj   +1 more source